Catalyst Wire Dossier Catalyst Wire Dossier

Saruparib

saruparib · AstraZeneca
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Saruparib, covering 2026-02-24 to 2026-04-21. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation [Phase 3]

See pricing